approval · primary record
MOXIFLOXACIN HYDROCHLORIDE
FDA · NDA · 2025-07-11
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-07-11 |
| Approval events | 1 |
| Brand | AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER |
| Sponsor | BAYER HLTHCARE |
| Route | INTRAVENOUS |
Approval history
1 action on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-07-11 | FDA | NDA | AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | BAYER HLTHCARE | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:32:08.235Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:moxifloxacin-hydrochloride
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Moxifloxacin Hydrochloride · compound